Raymond T. Doty

Raymond T. Doty

Auto-generated profile, based on publicly available information

Raymond T. Doty

Division of Hematology, Department of Medicine, University of Washington, Seattle, WA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2008 in Science
Verified
Journal Article
Closed access
PDF file
SKSiobán B. Keel
Siobán B. Keel
RDRaymond T. Doty
Raymond T. Doty
ZYZhantao Yang
Zhantao Yang
JQJohn Quigley
John Quigley
JCJing Chen
Jing Chen
JAJanis L. Abkowitz
Janis L. Abkowitz
Hemoproteins are critical for the function and integrity of aerobic cells. However, free heme is toxic. Therefore, cells must balance heme synthesis with its use. We previously demonstrated that the feline leukemia virus, subgroup C, receptor (FLVCR) exports cytoplasmic heme. Here, we show that FLVCR-null mice lack definitive erythropoiesis, have craniofacial and limb deformities resembling those of patients with Diamond-Blackfan anemia, and die in midgestation. Mice with FLVCR that is deleted neonatally develop a severe macrocytic anemia with proerythroblast maturation arrest, which suggests that erythroid precursors export excess heme to ensure survival. We further demonstrate that FLVCR mediates heme export from macrophages that ingest senescent red cells and regulates hepatic iron. Thus, the trafficking of heme, and not just elemental iron, facilitates erythropoiesis and systemic iron balance.

14 May 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TZTianming Zhou
Tianming Zhou
RZRuochi Zhang
Ruochi Zhang
DJDeyong Jia
Deyong Jia
RDRaymond T. Doty
Raymond T. Doty
AMAdam D. Munday
Adam D. Munday
JMJian Ma
Jian Ma

1 September 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ZYZhantao Yang
Zhantao Yang
JPJohn D. Philips
John D. Philips
RDRaymond T. Doty
Raymond T. Doty
PGPablo Giraudi
Pablo Giraudi
JOJ. Donald Ostrow
J. Donald Ostrow
JAJanis L. Abkowitz
Janis L. Abkowitz
The feline leukemia virus subgroup C receptor (FLVCR) is a heme export protein that is required for proerythroblast survival and facilitates macrophage heme iron recycling. However, its mechanism of heme export and substrate specificity are uncharacterized. Using [55Fe]heme and the fluorescent heme analog zinc mesoporphyrin, we investigated whether export by FLVCR depends on the availability and avidity of extracellular heme-binding proteins. Export was 100-fold more efficient when the medium contained hemopexin (Kd < 1 pm) compared with albumin (Kd = 5 nm) at the same concentration and was not detectable when the medium lacked heme-binding proteins. Besides heme, FLVCR could export other cyclic planar porphyrins, such as protoporphyrin IX and coproporphyrin. However, FLVCR has a narrow substrate range because unconjugated bilirubin, the primary breakdown product of heme, was not transported. As neither protoporphyrin IX nor coproporphyrin export improved with extracellular hemopexin (versus albumin), our observations further suggest that hemopexin, an abundant protein with a serum concentration (6.7–25 μm) equivalent to that of the iron transport protein transferrin (22–31 μm), by accepting heme from FLVCR and targeting it to the liver, might regulate macrophage heme export and heme iron recycling in vivo. Final studies show that hemopexin directly interacts with FLVCR, which also helps explain why FLVCR, in contrast to some major facilitator superfamily members, does not function as a bidirectional gradient-dependent transporter. Together, these data argue that hemopexin has a role in assuring systemic iron balance during homeostasis in addition to its established role as a scavenger during internal bleeding or hemolysis.

1 October 1995 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CLC L Law
C L Law
AAA Aruffo
A Aruffo
KCK A Chandran
K A Chandran
RDR T Doty
R T Doty
ECE A Clark
E A Clark
Baby hamster kidney cells transfected with murine CD22 (mCD22) mediate adhesion to B- and T-lineage cells. To further characterize mCD22-mediated cell adhesion, we generated a panel of recombinant globulins (Rg) consisting of different extracellular Ig-like (Ig) domains of mCD22. FACS analysis using these mCD22.Rgs revealed that ligands for mCD22 are expressed on both B and T cell lines and also normal B and T cells. In B-lineage cells, the expression of mCD22 ligands began on sIgM- pre-B cells in bone marrow. The ligand-binding site of mCD22 for ligands was mapped to Ig domains 1 and 2: mCD22.Rgs containing Ig domains 1 and 2 bound target cells and immunoprecipitated sets of glycoproteins similar to Rgs containing Ig domains 1 to 3 or all 7 CD22 Ig domains, whereas Rgs containing Ig domains 2 to 3 or 3 to 7 did not bind either B or T cells. Furthermore, B cells apparently expressed higher levels of mCD22 ligands than that of T cells, suggesting a potential competition for CD22 binding between ligands expressed on the same B cell and those expressed on another B cell or T cells. Immunoprecipitation experiments using the mCD22.Rgs identified mCD22 itself and the B cell-specific isoform of mCD45RA (B220) as two of the mCD22 ligands expressed on B cells. Thus, mCD22 may potentially regulate B cell activation through interactions with itself or mCD45RA/B220.

26 October 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
RDRaymond T. Doty
Raymond T. Doty
SPSusan R. Phelps
Susan R. Phelps
CSChristina Shadle
Christina Shadle
MSMarilyn Sanchez-Bonilla
Marilyn Sanchez-Bonilla
SKSiobán B. Keel
Siobán B. Keel
JAJanis L. Abkowitz
Janis L. Abkowitz
Erythropoiesis requires rapid and extensive hemoglobin production. Heme activates globin transcription and translation; therefore, heme synthesis must precede globin synthesis. As free heme is a potent inducer of oxidative damage, its levels within cellular compartments require stringent regulation. Mice lacking the heme exporter FLVCR1 have a severe macrocytic anemia; however, the mechanisms that underlie erythropoiesis dysfunction in these animals are unclear. Here, we determined that erythropoiesis failure occurs in these animals at the CFU-E/proerythroblast stage, a point at which the transferrin receptor (CD71) is upregulated, iron is imported, and heme is synthesized — before ample globin is produced. From the CFU-E/proerythroblast (CD71+ Ter119– cells) stage onward, erythroid progenitors exhibited excess heme content, increased cytoplasmic ROS, and increased apoptosis. Reducing heme synthesis in FLVCR1-defient animals via genetic and biochemical approaches improved the anemia, implying that heme excess causes, and is not just associated with, the erythroid marrow failure. Expression of the cell surface FLVCR1 isoform, but not the mitochondrial FLVCR1 isoform, restored normal rbc production, demonstrating that cellular heme export is essential. Together, these studies provide insight into how heme is regulated to allow effective erythropoiesis, show that erythropoiesis fails when heme is excessive, and emphasize the importance of evaluating Ter119– erythroid cells when studying erythroid marrow failure in murine models.

31 January 2019 in Blood
Verified
Journal Article
Closed access
PDF file
RDRaymond T. Doty
Raymond T. Doty
XYXiaowei Yan
Xiaowei Yan
CLChristopher Lausted
Christopher Lausted
AMAdam D. Munday
Adam D. Munday
ZYZhantao Yang
Zhantao Yang
JAJanis L. Abkowitz
Janis L. Abkowitz
Erythropoiesis is the complex, dynamic, and tightly-regulated process that generates all mature red blood cells. To understand this process, we mapped the developmental trajectories of progenitors from wildtype, erythropoietin-treated and Flvcr1-deleted mice at single cell resolution. Importantly, we linked the quantity of each cell9s surface proteins to its total transcriptome, which is a novel method. Deletion of Flvcr1 results in high levels of intracellular heme, allowing us to identify heme-regulated circuitry. Our studies demonstrate that in early erythroid cells (CD71+Ter119neg-lo), heme increases ribosomal protein transcripts; suggesting that heme, in addition to upregulating globin transcription and translation, guarantees ample ribosomes for globin synthesis. In later erythroid cells (CD71+Ter119lo-hi), heme decreases GATA1, GATA1-target gene, and mitotic spindle gene expression. These changes occur quickly. For example, in confirmatory studies using human marrow erythroid cells, ribosomal protein transcripts and proteins increase, and GATA1 transcript and protein decrease, within 15-30 minutes of amplifying endogenous heme synthesis with ALA. Since GATA1 initiates heme synthesis, GATA1 and heme together direct red cell maturation, and heme stops GATA1 synthesis, our observations reveal a GATA1-heme autoregulatory loop and implicate GATA1 and heme as the co-master regulators of the normal erythroid differentiation program. In addition, since excessive heme could amplify ribosomal protein imbalance, prematurely lower GATA1 and impede mitosis, these data may help explain the ineffective (early termination of) erythropoiesis in Diamond Blackfan anemia and del(5q) myelodysplasia, disorders with excessive heme in CFU-E/proerythroblasts; explain why these anemias are macrocytic; and show why children with GATA1 mutations have DBA-like clinical phenotypes. Key points Heme rapidly upregulates ribosomal protein genes during early erythropoiesis to help ensure sufficient ribosomes for globin translation. Heme later downregulates GATA1, GATA1-targets, and mitotic spindle genes to enable the normal termination of erythroid differentiation.